Back
Invesco S&P MidCap 400 GARP ETF Vs. Celldex Therapeutics, Inc. Industry Stock Comparison
Buy
55
GRPM
Invesco S&P MidCap 400 GARP ETF
Last Price:
$118.74
Seasonality Move:
3.59%
Sell
48
CLDX
Celldex Therapeutics, Inc.
Last Price:
$31.05
Seasonality Move:
20.93%
Buy
55
Invesco S&P MidCap 400 GARP ETF (GRPM)
is a Buy
Is Invesco S&P MidCap 400 GARP ETF a Buy, Sell or Hold?
-
The current Invesco S&P MidCap 400 GARP ETF [GRPM] share price is $119.13. The Score for GRPM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
GRPM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRPM Stock Price Chart
What is Invesco S&P MidCap 400 GARP ETF's stock price today?
-
The Invesco S&P MidCap 400 GARP ETF share price today is $119.13The current trend is relatively stagnant and GRPM is experiencing slight buying pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics, Inc.'s stock price today?
-
The Celldex Therapeutics, Inc. share price today is $31.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRPM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 51.43 | Buy |
| Chaikin Money Flow: | 4236 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (116.38 - 120.56) | Buy |
| Bollinger Bands (100): | (117.87 - 123.41) | Sell |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 55.97 | Buy |
| Chaikin Money Flow: | 3988094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.43 - 31.31) | Buy |
| Bollinger Bands (100): | (24.48 - 29.54) | Buy |
GRPM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.8 | Buy |
| 20-day SMA: | 117.59 | Buy |
| 50-day SMA: | 120.84 | Sell |
| 200-day SMA: | 118.55 | Buy |
| 8-day EMA: | 117.94 | Buy |
| 20-day EMA: | 118.3 | Buy |
| 50-day EMA: | 119.72 | Sell |
| 200-day EMA: | 118.2 | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.05 | Buy |
| 20-day SMA: | 30.57 | Buy |
| 50-day SMA: | 27.66 | Buy |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 30.94 | Buy |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.67 | Buy |
| 200-day EMA: | 26.26 | Buy |
Invesco S&P MidCap 400 GARP ETF Earnings Growth & GRPM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.
Invesco S&P MidCap 400 GARP ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||